期刊文献+

血管内皮生长因子和骨形态发生蛋白-2在糖尿病病人骨组织内表达水平的研究

Expression of vascular endothelial growth factor and bone morphogenetic protein-2 in bone tissue of diabetic patients
下载PDF
导出
摘要 目的探讨血管内皮生长因子(vascular endothelial growth factor, VEGF)、骨形态发生蛋白-2(bone morphogenetic protein-2, BMP-2)在糖尿病病人胫骨组织内的表达水平。方法在胫骨高位截骨术中,分别获取糖尿病病人(8例)和非糖尿病病人(8例)术部骨组织,从骨组织中提取总蛋白及RNA,用Western blot、RT-PCR检测骨组织中VEGF、BMP-2的表达水平。结果糖尿病病人骨组织中VEGF、BMP-2蛋白和mRNA表达水平均明显低于非糖尿病病人。结论糖尿病病人骨组织中VEGF、BMP-2因子表达低于正常水平,VEGF、BMP-2因子可能是影响糖尿病病人骨质及骨愈合的重要因素之一。 Objective To investigate the expression levels of vascular endothelial growth factor(VEGF) and bone morphogenetic protein-2(BMP-2) in the tibia of diabetic patients. Methods In the high osteotomy of the humerus, the bone tissues of diabetic patients(8 cases) and non-diabetic patients(8 cases)were obtained respectively. Total protein and RNA were extracted from bone tissue, and VEGF and BMP-2 in total bone tissue were detected by Western blot/RT-PCR. Results The expression levels of VEGF, BMP-2 mRNA and protein in bone tissue of diabetic patients were significantly lower than those in non-diabetic patients. Conclusion The expression of VEGF and BMP-2 in bone tissue of diabetic patients is lower than normal level. VEGF and BMP-2 may be one of the important factors affecting bone and bone healing in diabetic patients.
作者 张艳 李莹 张雪松 ZHANG Yan;LI Ying;ZHANG Xue-song(Department of Rehabilitation,Tangshan Second Hospital,Tangshan 063000,China;Department of Joint,Tangshan Second Hospital,Tangshan 063000,China)
出处 《骨科》 CAS 2019年第6期529-533,共5页 ORTHOPAEDICS
关键词 糖尿病 胫骨高位截骨术 血管内皮生长因子 骨形态发生蛋白-2 Diabetes High osteotomy Vascular endothelial growth factor Bone morphogenetic protein-2
  • 相关文献

参考文献11

二级参考文献115

  • 1Abdulbari Bener,Suhaila Ghuloum,Abdulla OAA Al-Hamaq,Elnour E Dafeeah.Association between psychological distress and gastrointestinal symptoms in diabetes mellitus[J].World Journal of Diabetes,2012,3(6):123-129. 被引量:5
  • 2冯伟,万荣,邓廉夫.骨优导修复骨缺损的实验研究[J].中国中医骨伤科杂志,2004,12(5):6-9. 被引量:2
  • 3钟刚,裴福兴,李胜富,樊瑜波.血管内皮生长因子基因转染促进成骨细胞增殖及其功能的实验研究[J].四川大学学报(医学版),2006,37(1):44-47. 被引量:10
  • 4高小亚,戈敏娟,马向华.单纯性肥胖患者血清瘦素、抵抗素和脂联素水平的研究[J].医学研究生学报,2006,19(6):544-547. 被引量:25
  • 5Ma L, Oei L, Jiang L, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies [J]. Eur J Epidemiol, 2012, 27:319-332.
  • 6Sealand R, Razavi C, Adler RA. Diabetes mellitus and osteoporosis[J]. Curr Diab Rep, 2013, 13 411-418.
  • 7Donaldson MG, Cawthon PM, Lui LY, et al. Estimates of the proportion of older white women who would be recommended {or pharmacologic treatment by the new US National Osteoporosis Foundation Guidelines[J]. J Bone Miner Res, 2009, 24675-680.
  • 8Donaldson MG, Cawthon PM, Lui LY, et al. Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation Guidelines[J]. J Bone Miner Res, 2010, 25.. 1506-1511.
  • 9Melton LJ, 3rd, Leibson CL, Achenbach SJ, et al. Fracture risk in type 2 diabetes: update of a population-based study[J]. J Bone Miner Res, 2008, 23:1334-1342.
  • 10Ettinger B, Liu H, Blackwell T, et al. Validation of FRC, a fracture risk assessment tool, in a cohort of older men: The Osteoporotic Fractures in Men (MrOS) Study[J]. J Clin Densitom, 2012, 15.. 334-342.

共引文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部